Long-term changes in serum gastrin levels during standard dose vonoprazan therapy
Sign Up to like & getrecommendations! Published in 2022 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2022.2097893
Abstract: Abstract Background Long-term acid suppression during vonoprazan therapy causes hypergastrinemia which may induce gastric mucosal changes such as fundic gland and hyperplastic polyps. The aim of this study is to clarify the long-term changes in… read more here.
Keywords: long term; serum gastrin; gastrin levels; vonoprazan therapy ... See more keywords
Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease.
Sign Up to like & getrecommendations! Published in 2021 at "Biomedical reports"
DOI: 10.3892/br.2021.1408
Abstract: Vonoprazan, a novel potassium-competitive acid blocker, results in greater inhibition of gastric acid secretion than proton pump inhibitors (PPI). The aim of this study was to assess the long-term outcomes of patients with PPI-resistant gastroesophageal… read more here.
Keywords: vonoprazan therapy; erosive group; group; non erosive ... See more keywords